• 繁

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Revvity (RVTY) Pushes Its AI Story, Is The Upside Already Priced In?

    Simply Wall St·11/01/2026 13:39:33
    語音播報

    Revvity (RVTY) is back in focus after the board declared a regular quarterly dividend of $0.07 per share, a small cash return that lands just ahead of a closely watched earnings release.

    Revvity’s shares have pulled back 5.3% on a 1-day share price basis and slipped 1.1% over the past week, even after strong gains that left the 90-day share price return at 36.3% and the 1-year total shareholder return at 68.2%. This suggests that recent enthusiasm around AI tools like Signals LabGistics and the upcoming earnings release is being tempered by some investors reassessing risk and valuation at the current US$157.00 level.

    Scan how Revvity’s AI push compares with other potential movers by lining it up against 41 profitable AI stocks that aren't just burning cash that pair real earnings power with exposure to similar themes.

    After a 68.2% 1-year total return and a recent pullback to around US$157, Revvity now sits at an awkward crossroads. Is most of the AI and diagnostics optimism already priced in, or is there still meaningful upside left?

    Most Popular Narrative: 6% Overvalued

    Revvity is trading at $157.00 against a narrative fair value of about $147.53, so the current price already leans ahead of that widely followed view and leaves less room for missteps.

    The current valuation suggests that investors are already paying a premium for sustained growth in areas such as Signals software, reproductive health, and ex-China immunodiagnostics, even though the company’s longer-term revenue and EPS trends have been under pressure.

    See why 10 investors see Revvity as 6% overvalued.

    Result: Fair Value of $147.53 (OVERVALUED)

    Still, if Signals software regains high teens reported growth, or if reproductive health and ex China immunodiagnostics keep outperforming, that could pressure the current overvaluation story.

    Find out about the key risks to this Revvity narrative.

    Next Steps

    Mixed messages in the Revvity story today. Act quickly by testing the numbers, weighing the risks and rewards, and then checking the 1 key reward and 2 important warning signs.

    Looking for more Revvity-sized investment ideas?

    Do not stop your research with Revvity alone. Broaden your watchlist with targeted ideas that match your risk, income, and quality preferences using focused stock screens.